DoD Melanoma, Survivorship Research Award
ID: 358948Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358948
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Melanoma Survivorship Research Award to support innovative research aimed at enhancing the health and well-being of melanoma survivors and their caregivers. This grant encourages collaborative research that integrates insights from melanoma consumers, with a focus on various aspects of survivorship, including psychological impacts, symptom management, and healthcare delivery challenges, while explicitly excluding studies limited to animal models or survival rates without quality of life considerations. The total estimated program funding is $2,320,000, with a maximum award amount of $725,000 per project over a three-year performance period. Interested applicants must submit a pre-application by September 10, 2025, followed by a full application due by October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942525MRPSRA_GG.pdf
    The Department of Defense (DOD) announces the FY25 Melanoma Survivorship Research Award under the Defense Health Program to support innovative research aimed at improving the health and well-being of melanoma survivors and their caregivers. This program seeks to foster collaborative efforts that incorporate melanoma consumer insights into the research process. Applicants must submit a pre-application by September 10, 2025, followed by a full application due by October 1, 2025, targeting a maximum funding of $725,000 per award over a 3-year performance period. The program emphasizes research on various aspects of melanoma survivorship, including psychological impacts, symptom management, and healthcare delivery challenges. Strategies should address long-term effects of treatment and methods to improve quality of life while avoiding studies limited to animal models or survival rates without quality of life considerations. Key eligibility criteria include having a Principal Investigator from eligible organizations and mandatory collaboration with melanoma consumer partners. The application process involves detailed submission requirements, including budget formulations and clear evidence of support from collaborators. This funding opportunity reflects a commitment to enhancing melanoma care and aligns with military health considerations, aiming to bridge gaps in current research and treatment protocols.
    Similar Opportunities
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Department of Defense HIV/AIDS Prevention Program
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a federal grant opportunity titled the Department of Defense HIV/AIDS Prevention Program (DHAPP). This program aims to save lives and prevent HIV infections by supporting the development of interventions and programs within military health systems, particularly in foreign countries, to achieve HIV/AIDS epidemic control. The DHAPP focuses on enhancing military capacity for ownership and behavioral change, aligning with national strategies, and ensuring sustainable HIV prevention and treatment services. Interested applicants can reach out to Ebony Simmons at ebony.s.simmons.civ@health.mil or by phone at 301-619-2105 for further information. The application deadline is September 18, 2027, with an expected seven awards to be made under this cooperative agreement, which does not require cost sharing or matching.
    Staff Research Program
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity for the Staff Research Program, aimed at engaging scientific staff in collaborative research with higher education institutions. This program seeks to enhance the professional competence of Army Research Office (ARO) scientists through hands-on, fundamental research in various scientific fields, including engineering, physical sciences, and life sciences, with a focus on advancing knowledge relevant to Army missions. Eligible applicants include institutions recognized for their scientific research capabilities, and the funding will be provided through cooperative agreements with award amounts ranging from $200,000 to $10 million. Proposals must be submitted via Grants.gov by June 2, 2030, and interested parties can contact Mr. William Creech at William.a.creech3.civ@army.mil for further information.
    Military and Civilian Partnership for Trauma Readiness Grant Program/Mission Zero
    Admin for Strategic Preparedness and Response
    The Administration for Strategic Preparedness and Response is offering the Military and Civilian Partnership for Trauma Readiness Grant Program, also known as the Mission Zero Act, to support high-acuity trauma centers in enhancing military-civilian partnerships for improved trauma care. This grant program aims to award up to 30 eligible trauma centers, enabling military trauma teams to provide full-time trauma and acute care services, thereby strengthening the nation's response to public health and medical emergencies. With an estimated total program funding of $4 million and an award ceiling of $4 million per grant, interested applicants, including nonprofits without 501(c)(3) status and hospitals, should note that the application period is expected to open on January 15, 2025, with a closing date of April 14, 2025. For further inquiries, applicants can contact Leslie Beck at 301-346-4857 or via email at leslie.beck@hhs.gov.
    Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced a funding opportunity titled "Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies." This initiative aims to support innovative research projects that investigate the adverse effects of cancer therapies, particularly those that lead to chronic comorbidities or delayed sequelae, with a focus on understanding the underlying mechanisms and developing therapeutic strategies to mitigate these long-term issues. The funding is open to a diverse range of applicants, including educational institutions, non-profits, and foreign organizations, and requires a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Applications must be submitted electronically by January 5, 2025, with awards contingent on available funding and merit assessed through NIH's peer-review process. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Tactical Behaviors for Autonomous Maneuver
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity through the Tactical Behaviors for Autonomous Maneuver Collaborative Research Program (TBAM-CRP) aimed at enhancing the capabilities of robotic and autonomous systems (RAS) for military operations in complex environments. This program seeks proposals that develop coordinated and adaptive behaviors for small groups of autonomous agents, focusing on innovative maneuver tactics and strategies to operate effectively in multi-domain operations against peer adversaries. The TBAM-CRP is critical for advancing military capabilities, leveraging new technologies in robotics and autonomous systems to improve situational awareness and operational effectiveness on the battlefield. Interested applicants, including institutions of higher education and for-profit organizations, are invited to submit proposals by April 24, 2024, with funding amounts ranging from $100,000 to $2.3 million available per award. For further inquiries, applicants can contact Christopher D. Justice at usarmy.adelphi.devcom-arl.mbx.tbam-crp-questions@army.mil.
    Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Method to Extend Research in Time (MERIT) Award Extension, aimed at providing extended grant support to Early Stage Investigators (ESIs) who have shown strong research potential and received favorable evaluations on their R01 applications. This funding opportunity allows for up to seven years of support in two segments, enabling ESIs to establish their careers while focusing on critical cancer research areas such as identifying cancer risks, improving early detection strategies, and developing treatment methods. Interested applicants, including a diverse range of institutions such as Historically Black Colleges and Universities and Tribal Colleges, must adhere to specific application guidelines and register with Grants.gov and eRA Commons, with applications opening on February 3, 2025, and due by March 3, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Metastasis Research Network (U54 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Metastasis Research Network (U54 Clinical Trial Not Allowed), aimed at advancing research on cancer metastasis through the establishment of specialized centers. Applicants are required to propose a cohesive scientific theme supported by two or three interdisciplinary research projects that utilize integrative system-level approaches to understand the complexities of metastasis, including factors such as early dissemination and cellular responses to therapies. This initiative is crucial for enhancing our understanding of metastasis as a systemic issue across various cancer types, including rare and pediatric cancers. The total estimated funding for this program is $6.8 million, with individual awards capped at $1.7 million, and the application deadline is expected to close on May 15, 2026. For further inquiries, interested parties can contact Joanna M. Watson, Ph.D., at 240-276-6206 or via email at watsonjo@mail.nih.gov.
    NFRP Outreach and Invitation for Response
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is forecasting an opportunity for a Research-based Other Transactions Agreement (rOTA) under the Neurofibromatosis Research Program (NFRP). This initiative aims to accelerate the clinical translation of basic research related to neurofibromatosis (NF) by conducting collaborative Phase I and II clinical trials focused on promising therapeutic agents for NF1, NF2, and schwannomatosis. Historically, this requirement has been addressed through assistance agreements, and the government is now seeking feedback on this proposed approach, emphasizing the need for cost-sharing arrangements and access to patient populations. Interested parties can direct inquiries to Jason D. Kuhns at jason.d.kuhns.civ@mail.mil, with the opportunity being part of the FY21 portfolio and requiring a demonstrated history of collaborative research among participants.
    US Army Combat Capabilities Development Command Broad Agency Announcement
    ACC APG - Natick
    The U.S. Army Combat Capabilities Development Command (DEVCOM) Soldier Center is inviting proposals through its Broad Agency Announcement (BAA) for scientific research and experimentation aimed at advancing state-of-the-art technologies. The BAA seeks innovative solutions in various areas, including combat feeding systems, soldier protection, human performance, and simulation technologies, without focusing on specific hardware solutions. This opportunity is crucial for enhancing military capabilities and overcoming existing technological barriers. Interested applicants, including universities, nonprofit research institutes, and commercial firms, must submit their proposals by February 27, 2030, with the potential for up to 1,500 awards. For further details, contact Lyndon Jagroop at 347-676-8382 or via email at lyndon.s.jagroop.civ@army.mil, and refer to the full announcement on SAM.gov.